Key facts
- Salutare’s last known valuation is $14.4M (Dec 2025).
- It has raised $870K; the latest was Angel (individual) ($870K) in Dec 2025.
- Notable investors include ABHI US Accelerator, Health Innovation North West Coast.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Salutare
- ·The full record, as it builds
Funding rounds
No funding rounds for Salutare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Salutare
Developer of a clinical workflow software designed to prevent patients from being lost in the healthcare system. The company offers integrated referral management, digital phlebotomy tracking, and pre-analytical automation, enabling hospitals and healthcare providers to streamline diagnostics, improve patient safety, and reduce administrative errors.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2020
- Employees
- 6
- Website
- salutare.co.uk/
- Ownership
- Privately Held (backing)
Salutare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salutare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salutare in its N-PORT filings yet. We sweep new filings monthly.